 This is a wonderful summit that actually brings a lot of scientists from different specialties together to function as a team. When we treat patients with cancer, we treat them with chemotherapy. The reason they fail is because the tumor cells become resistant to the chemotherapeutics. So the drugs that we give them no longer work to kill cancer cells. And the reason for that is thought to be the stem cells. So the stem cells that we identify are very similar in many ways to the stem cells that they are using to treat, say a rotator cuff repair. Over the past 30 years, our ability to treat the primary malignant bone and soft tissue cancers has not really improved as much as we would have liked. So we need new ways of approaching new personalized medicine to be able to treat these patients. And to learn more about these cancers. And I think that some of the events that are happening this summit, some of the things that are being talked about, will be very helpful in furthering some of the research and potentially some of the phase one clinical trials. When you bring in different perspectives or different disciplines, you look at problems from a different point of view. That helps us solve problems in different ways that have never been thought before.